Case Study: a leading diagnostic company achieves 97% sepsis diagnostic accuracy with Meta-Flux

AI-driven analysis of bacterial, viral, and post-operative pathways with 97% diagnostic accuracy

The Leading Diagnostic Company faced a challenge in sepsis research, where its initial use of conventional statistical techniques like PCA and PLS-DA achieved only approximately 70% accuracy in distinguishing sepsis pathways. These traditional methods failed to identify statistically significant markers from the literature and provided limited insights for new therapeutic development.

Meta-Flux addressed this by applying its deep graph neural network analysis to re-examine the raw patient data. This solution successfully captured complex, non-linear relationships, achieving a 97% diagnostic accuracy and identifying key predictive biomarkers. The results from Meta-Flux provided a scalable framework for the customer and delivered actionable insights for future therapeutic validation and development.